Systematic Reviews
Copyright ©The Author(s) 2025.
World J Stem Cells. Jul 26, 2025; 17(7): 108519
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.108519
Table 5 On-going clinical trials registered on ClinicalTrials.gov, Clinical Trials Registry - India, and Chinese Clinical Trial Register till February 2025, evaluating the safety and/or efficacy of exosomes for hair regeneration
Study identifier
Title of the study
Source of exosomes
Study phase; estimated enrollment (n)
Primary outcome measure(s)
Recruitment status
Study location(s)
NCT06571799Study evaluating the efficacy and safety of BENEV exosome regenerative complex+ for self-perceived thinning hairAdipose tissue stem cell-derived exosomesNot applicable; n = 30Change in terminal hair counts, change in vellus hair counts, change in total hair counts (time frame: Baseline to day 120 or end of study visit)CompletedUnited States
NCT05658094Exosome effect on prevention of hair lossHuman amniotic mesenchymal stem cells-derived exosomesNot applicable; n = 20Change in mean total hair density (hair/cm2) (time frame: 0, 3 and 6 months), visual assessment before and after (time frame: 6 months)UnknownIran
NCT06482541Efficacy and safety of AGE ZERO™ exosomes to treat men and women with androgenetic alopeciaWharton’s jelly mesenchymal stem cell-derived exosomePhase I; n = 100Hair count, hair thickness, hair color (time frame: Evaluated on monthly visits for a year)Not yet recruitingUnited States
NCT06539273Exosome treatment in androgenetic alopeciaForeskin-derived mesenchymal stromal cells derived exosomePhase III; n = 30Hair density (time frame: 4 and 12 weeks)CompletedTurkey
NCT06697080Umbilical cord-derived mesenchymal stem cell exosomes on hair growth in patients with androgenetic alopeciaUmbilical cord-derived mesenchymal stem cell exosomesNot applicable; n = 50Hair diameters changed over time (time frame: 0 days, 1 month, 3 months, 6 months)Active, not recruitingChina